Aprea Therapeutics, Inc. (APRE) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$285.8K

Net Income/Loss (FY2025)

-$12.6M

Total Assets (FY2025)

$15.9M

Total Equity (FY2025)

$12.4M

Cash Flows from Operating Activities (FY2025)

-$12.9M

Source: Aprea Therapeutics, Inc. 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.